Growth Metrics

Biocryst Pharmaceuticals (BCRX) Current Assets: 2010-2014

Historic Current Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $89.3 million.

  • Biocryst Pharmaceuticals' Current Assets fell 37.47% to $84.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $84.5 million, marking a year-over-year decrease of 37.47%. This contributed to the annual value of $89.3 million for FY2014, which is 112.11% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Current Assets of $89.3 million as of FY2014, which was up 112.11% from $42.1 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Current Assets registered a high of $89.3 million during FY2014, and its lowest value of $42.0 million during FY2012.
  • Its 3-year average for Current Assets is $57.8 million, with a median of $42.1 million in 2013.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Current Assets tumbled by 39.53% in 2011, and later surged by 112.11% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Current Assets (Yearly) stood at $87.4 million in 2010, then tumbled by 39.53% to $52.9 million in 2011, then declined by 20.58% to $42.0 million in 2012, then rose by 0.34% to $42.1 million in 2013, then soared by 112.11% to $89.3 million in 2014.